Four years after Sanofi shelled out $125 million for global rights to Biond Biologic | The company is handing back the tumor ...

William Pao, former Roche R&D leader and Pfizer CDO, now leads Revelio Therapeutics (formerly Launchpad) as CEO, joins ...

The company's molecular research and drug-development platform taps what it calls nature's wisdom to drive the discovery of ...

Novavax on Thursday posted a narrower fourth-quarter loss and said it expects its licensing deal with French drugmaker Sanofi ...

French biotech start-up studio Argobio and non-profit biomedical research center the Institut Pasteur have announced the ...

Sanofi's Sarclisa (isatuximab) has gained approval from Japan’s Ministry of Health, Labour and Welfare for use in conjunction ...

An experimental drug being developed by Sanofi significantly curbed progression of aortic valve stenosis, a common heart ...